Sam Arbesman is the Scientist-In-Residence @ Lux Capital, the fund that supports scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time, the more ambitious the project, the better. Sam works with companies and founders that recognize the future happens at the boundaries of science and technology infusing computation into everything from biology to manufacturing.Sam’s scientific research has been published in everything from the Wall Street Journal to The New York Times and The Atlantic. Sam is also the author of the award-winning The Half-Life of Facts and the new book Overcomplicated: Technology at the Limits of Comprehension.
Share this post
20VC: Lux Capital's Scientist-In-Residence on…
Share this post
Sam Arbesman is the Scientist-In-Residence @ Lux Capital, the fund that supports scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time, the more ambitious the project, the better. Sam works with companies and founders that recognize the future happens at the boundaries of science and technology infusing computation into everything from biology to manufacturing.Sam’s scientific research has been published in everything from the Wall Street Journal to The New York Times and The Atlantic. Sam is also the author of the award-winning The Half-Life of Facts and the new book Overcomplicated: Technology at the Limits of Comprehension.